AVTRAvantor, Inc.
Laboratory Analytical Instruments
- Revenue
- $6.6B
- 3.4% YoY
- Operating margin
- -3.8%
- 123% YoY
- EBITDA
- $164M
- 89% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 19.6×
- $3.2B net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowClear12% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyFired42% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $7.4B | $7.5B | $7.0B | $6.8B | $6.6B | 3.4% |
| Operating income | $972M | $1.1B | $696M | $1.1B | −$246M | 123% |
| Net income | $573M | $687M | $321M | $712M | −$530M | 175% |
| Operating cash flow | $954M | $844M | $870M | $841M | $624M | 26% |
| Capex | $111M | $133M | $146M | $149M | $129M | 13% |
| Stock-based comp | $51M | $46M | $41M | $47M | $46M | 0.9% |
| Buybacks | — | — | $0 | $0 | $75M |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
No pay-versus-performance disclosure yet.